These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27004544)

  • 1. [The first LENUS pro® pump implantation in Poland in patient with pulmonary hypertension].
    Pawlak A; Koteja A; Starska A; Kurzyna M; Gil RJ
    Kardiol Pol; 2016; 74(3):300. PubMed ID: 27004544
    [No Abstract]   [Full Text] [Related]  

  • 2. An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil.
    Kurzyna M; Małaczyńska-Rajpold K; Koteja A; Pawlak A; Chrzanowski Ł; Furdal M; Gąsior Z; Jacheć W; Sobkowicz B; Norwa J; Mularek-Kubzdela T; Torbicki A
    BMC Pulm Med; 2017 Dec; 17(1):162. PubMed ID: 29195500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous treprostinil infusion via a fully implantable pump for pulmonary arterial hypertension.
    Ewert R; Richter MJ; Steringer-Mascherbauer R; Grünig E; Lange TJ; Opitz CF; Warnke C; Ghofrani HA
    Clin Res Cardiol; 2017 Oct; 106(10):776-783. PubMed ID: 28429083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable LENUS pro pump for treprostinil infusion in three pediatric patients.
    Álvarez-Fuente M; Garrido-Lestache E; Rivero N; Centella T; Lamas MJ; Pérez-Caballero C; Vázquez JL; Del Cerro MJ
    Pediatr Pulmonol; 2020 May; 55(5):1254-1258. PubMed ID: 32149476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "bouncing" catheter.
    Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T
    Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062
    [No Abstract]   [Full Text] [Related]  

  • 6. A case series of patients with severe pulmonary hypertension receiving an implantable pump for intravenous prostanoid therapy.
    Ewert R; Halank M; Bruch L; Ghofrani HA
    Am J Respir Crit Care Med; 2012 Dec; 186(11):1196-8. PubMed ID: 23204382
    [No Abstract]   [Full Text] [Related]  

  • 7. Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension.
    Richter MJ; Ewert R; Warnke C; Gall H; Classen S; Grimminger F; Mayer E; Seeger W; Ghofrani HA
    Clin Res Cardiol; 2017 Mar; 106(3):174-182. PubMed ID: 27670656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treprostinil for pulmonary hypertension.
    Vachiéry JL; Naeije R
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):183-91. PubMed ID: 15151467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treprostinil for the treatment of pulmonary arterial hypertension in patients with New York Heart Association class II-IV symptoms.
    Herald N; Laliberte K
    Pharmacotherapy; 2006 Aug; 26(8):1203; discussion 1203-4. PubMed ID: 16863500
    [No Abstract]   [Full Text] [Related]  

  • 10. Moderate-term effect of epoprostenol on severe portopulmonary hypertension.
    Kato H; Katori T; Nakamura Y; Kawarasaki H
    Pediatr Cardiol; 2003; 24(1):50-3. PubMed ID: 12574979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term safety and outcome of intravenous treprostinil via an implanted pump in pulmonary hypertension.
    Richter MJ; Harutyunova S; Bollmann T; Classen S; Gall H; Gerhardt Md F; Grimminger F; Grimminger J; Grünig E; Guth S; Halank M; Heine A; Hoeper MM; Klose H; Lange TJ; Meyer K; Neurohr C; Nickolaus K; Olsson KM; Opitz CF; Rosenkranz S; Seyfarth HJ; Warnke C; Wiedenroth C; Ghofrani HA; Ewert R
    J Heart Lung Transplant; 2018 Oct; 37(10):1235-1244. PubMed ID: 30293617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in prostacyclin therapy for pulmonary arterial hypertension.
    Eells PL
    Crit Care Nurse; 2004 Apr; 24(2):42-8, 50-4. PubMed ID: 15098310
    [No Abstract]   [Full Text] [Related]  

  • 13. Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension.
    Desole S; Velik-Salchner C; Fraedrich G; Ewert R; Kähler CM
    Heart Lung; 2012; 41(6):599-605. PubMed ID: 22920608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The combined use of sildenafil with epoprostenol in a patient with primary pulmonary hypertension].
    Kayikçioğlu M; Can LH; Payzin S; Kültürsay H; Soydan I
    Anadolu Kardiyol Derg; 2002 Sep; 2(3):262-4. PubMed ID: 12223337
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostacyclin in the intensive care setting.
    Ivy DD
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S41-5. PubMed ID: 20216163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin withdrawal in pulmonary hypertension #264.
    Bartlett C; Landzaat L;
    J Palliat Med; 2013 Feb; 16(2):204-5. PubMed ID: 23336356
    [No Abstract]   [Full Text] [Related]  

  • 17. Advances in prostanoid infusion therapy for pulmonary arterial hypertension.
    Doran A; Harris S; Goetz B
    J Infus Nurs; 2008; 31(6):336-45. PubMed ID: 19018187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy.
    Stewart R; Tuazon D; Olson G; Duarte AG
    Chest; 2001 Mar; 119(3):973-5. PubMed ID: 11243988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Rebound effect after prostacyclin inhalation in pulmonary hypertension].
    Moro JA; Almenar L; Morales P; Osa A
    Med Clin (Barc); 2007 Jul; 129(7):279. PubMed ID: 17683713
    [No Abstract]   [Full Text] [Related]  

  • 20. Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension.
    Levy M; Celermajer DS; Bourges-Petit E; Del Cerro MJ; Bajolle F; Bonnet D
    J Pediatr; 2011 Apr; 158(4):584-8. PubMed ID: 21035821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.